Search results for "Breast Cancer"


 
Results 61 - 70 of about 233 for "Breast Cancer".
Sort by: Relevance | Newest | Oldest

Modeling study finds benefit in personalized mammogram schedules

Personalized mammography schedules based on women's individual risk factors could be more beneficial and cost-effective than generalized recommendations, according to a new modeling study.
https://immattersacp.org/weekly/archives/2011/07/12/1.htm
12 Jul 2011

New drugs approved for type 2 diabetes and COPD

This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014

History is key after childhood disease

A generation ago, most children with severe disabilities died before reaching adulthood. Now, more than 90% survive. From cancer or congenital heart disease to cystic fibrosis and Down syndrome, pediatric survivors need interns who can coordinate chronic care.
https://immattersacp.org/archives/2010/09/pediatrics.htm
1 Sep 2010

New CBC test, implant for apnea approved

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2018/01/new-cbc-test-implant-for-apnea-approved.htm
1 Jan 2018

Internist involvement crucial to easing early menopause

Assessments for the potential symptoms of menopause should begin when women are in their 40s and may be entering perimenopause.
https://immattersacp.org/archives/2017/09/internist-involvement-crucial-to-easing-early-menopause.htm
1 Sep 2017

First Ebola vaccine approved; FDA enforcement on e-cigs

This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/03/first-ebola-vaccine-approved-fda-enforcement-on-e-cigs.htm
1 Mar 2020

Warfarin recalled, type 2 diabetes drug approved

Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/07/fda.htm
1 Jul 2011

Recurrence of estrogen-receptor-positive early-stage breast cancer after endocrine therapy associated with TN status at diagnosis

Patients with stage T1 disease had a 13% risk of distant recurrence with no nodal involvement, 20% risk with involvement of one to three nodes, and 34% risk with involvement of four to nine nodes.
https://immattersacp.org/weekly/archives/2017/11/14/2.htm
14 Nov 2017

Rethinking advance care planning

While more physicians are reporting having conversations about advance care planning with their patients, it's still far from common.
https://immattersacp.org/archives/2022/05/rethinking-advance-care-planning.htm
1 May 2022

Menopausal hormone therapy linked to breast cancer risk

An individual patient-level meta-analysis found that risk for breast cancer increased steadily with duration of use for all types of menopausal hormone therapy except vaginal estrogen and that risk was higher with estrogen-progestogen than estrogen-only formulations.
https://immattersacp.org/weekly/archives/2019/09/10/1.htm
10 Sep 2019

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next